Thomas Eldered, CEO

Welcome

Mark Quick, EVP Corporate Development

Business case

Thomas Eldered, CEO

Strategy update

AGENDA
Tobias Hägglöv, CFO
Financial update and financial targets

CAPITAL MARKETS DAY Jean Stephenson, General Manager Recipharm in Holmes Chapel
2019 Becoming part of Recipharm

Kjell Johansson, President Manufacturing Services Europe

Stockholm | November 18 Manufacturing Services Europe

Bernard Pluta, President Development Services

Development Services – a global offering

Jean-Francois Hilaire, EVP Strategy & Global Integration

Utilizing global strength

Jean-Francois Hilaire, EVP Strategy & Global Integration

Innovation and new service offerings

Thomas Eldered, CEO

Q&A and concluding remarks
1
HOLMES CHAPEL – BECOMING PART OF RECIPHARM
Jean Stephenson
 A BRIEF HISTORY

• Origin of our company, Fisons, goes back as far as 1938

• Transition from a general wellbeing healthcare supplier to a
pharmaceutical supplier in 1968
• A journey began, establishing ourselves as a respected player
in the field of inhaled medicine Glasgow Edinburgh

• This journey continued through a series of acquisitions and

mergers 1995 – 2004 as part of ‘big pharma’ companies
• Our most recent transition in October 2018 brought about the
Liverpool Manchester
most significant change in our history
Holmes Chapel
• A move out of big pharma into the contract development
and manufacturing space
London
• We became a part of the Recipharm Group

• A significant turning point for our operations

3
 OUR INHALATION BUSINESS

Successful supplier of inhaled medicines, treating asthma and

chronic obstructive pulmonary disease (COPD) for over 40 years

Industrialisation track record

• Commercialised new products for third party customers

• Pilot scale capability for multiple products

• Clinical manufacturing capability

But, we needed something more to ensure a sustainable future for

our operation…Recipharm has given us that opportunity

4
 CLEAR CHANGES

• Transitioning 470 people into Recipharm felt seamless

• Autonomy to develop and implement processes that add value
for our company, non-prescriptive at Group level
• Released from the resource intensive administrative processes
necessary to manage and control within big pharma
• Decisions that affect our company are ours to make
• More impactful decisions are made between myself and my
immediate line manager
• A very competent and accessible network of support available
to us
• Regular, face to face contact with our Board members is
quickly building confidence and trust

5
 RAPIDLY GROWING OUR INHALATION BUSINESS

We have been given the freedom to work with a sister company to develop a
strategy and a new brand: Recipharm Inhalation Solutions™
• Launched earlier this year at RDD

An effective Recipharm Business Development Team

• Providing 17 new leads vs approximately 30 leads in the previous 10 years in big pharma

• Growing our industry network

• Engaging our people in the fast paced, dynamic aspect of attracting new business

A new (standard Recipharm) role within our company of Commercial Manager

• Bringing the inhalation strategy to life
• Enhancing our reputation thereby attracting interest

For the first time, we have secured a new DPI opportunity that extends the
therapeutic reach of inhaled medicines beyond respiratory treatment
• This really is a huge opportunity for the use of inhaled medicines

6
 IN SUMMARY

• The past year has been an exciting time for the team at Holmes Chapel
• We have operated more independently, grown our network
• And yet support is always on hand

• We have been actively encouraged to be more entrepreneurial, taking

greater ownership for our future
• We have seen a surge of enquiries and leads from new and existing
customers
• We have already secured new business

• We have been able to provide genuine development opportunities for

our people
• Establishing a more motivated, skilled and responsive team ready for the
challenges of multi product growth

• The goal of providing a more secure future for our company is very
much in sight

7
 THE POSITIVE INDICATIONS OF WORKING WITH RECIPHARM

Pharmaceutical expertise

Managing complexity

Full service offering

Risk control

Good value for money